Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: A multicentre observational study

Critical Care

Volumn 18, Issue 2, 2014, Pages

  Hagemo, Jostein S ^a,b   Stanworth, Simon ^c   Juffermans, Nicole P ^d   Brohi, Karim ^e   Cohen, Mitchell J ^f   Johansson, Pär I ^g,h   Røislien, Jo ^a,i   Eken, Torsten ^b   Næss, Paal A ^b   Gaarder, Christine ^b  

^a Department of Research Norwegian Air Ambulance Stiftelsen Norsk Luftambulanse ^*  (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

^h UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ADULT; ALKALOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPOFIBRINOGENEMIA; INJURY SCALE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; TIME; AFIBRINOGENEMIA; CLINICAL TRIAL; EMERGENCY TREATMENT; MIDDLE AGED; PREDICTIVE VALUE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TRENDS; WOUNDS AND INJURIES; YOUNG ADULT;

ADULT; AFIBRINOGENEMIA; EMERGENCY TREATMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84901319861     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13798     Document Type: Article

References (40)

1. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT. Epidemiology of trauma deaths: a reassessment. J Trauma Injury Infect Crit Care 1995, 38:185-193.
2. Groven S, Eken T, Skaga NO, Røise O, Naess PA, Gaarder C. Long-lasting performance improvement after formalization of a dedicated trauma service. J Trauma 2011, 70:569-574. 10.1097/TA.0b013e31820d1a9b, 21610344.
3. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 2007, 13:680-685. 10.1097/MCC.0b013e3282f1e78f, 17975390.
4. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005, 3:1894-1904. 10.1111/j.1538-7836.2005.01365.x, 16102057.
5. Martini WZ. The effects of hypothermia on fibrinogen metabolism and coagulation function in swine. Metab Clin Exp 2007, 56:214-221. 10.1016/j.metabol.2006.09.015, 17224335.
6. Martini WZ. Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs. AJP Endocrinol Metab 2005, 289:E930-E934.
7. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010, 105:116-121. 10.1093/bja/aeq161, 20627882.
8. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet JF. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma Injury Infect Crit Care 2008, 64:1211-1217.
9. Cohen MJ, Call M, Nelson M, Calfee CS, Esmon CT, Brohi K, Pittet JF. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg 2012, 255:379-385. 10.1097/SLA.0b013e318235d9e6, 3549308, 22133894.
10. Levy JH, Szlam F, Tanaka KA, Sniecienski RM. Fibrinogen and hemostasis. Anesth Analg 2012, 114:261-274. 10.1213/ANE.0b013e31822e1853, 21965371.
11. Stanworth SJ, Hunt BJ. The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding. Crit Care 2011, 15:1006. 10.1186/cc10510, 3388654, 22082120.
12. Tisherman SA. Is fibrinogen the answer to coagulopathy after massive transfusions?. Crit Care 2010, 14:154. 10.1186/cc9000, 2911703, 20497599.
13. Schöchl H, Maegele M, Solomon C, Görlinger K, Voelckel W. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 2012, 20:15. 10.1186/1757-7241-20-15, 3306198, 22364525.
14. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Filipescu D, Hunt B, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013, 17:R76. 10.1186/cc12685, 23601765.
15. Fries D. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. Transfusion 2013, 53:91S-95S.
16. Schöchl H, Cotton B, Inaba K, Nienaber U, Fischer H, Voelckel W, Solomon C. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011, 15:R265. 10.1186/cc10539, 3388656, 22078266.
17. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma Injury Infect Crit Care 2003, 54:1127-1130.
18. Rixen D, Siegel JH. Bench-to-bedside review: oxygen debt and its metabolic correlates as quantifiers of the severity of hemorrhagic and post-traumatic shock. Crit Care 2005, 9:441-453. 10.1186/cc3526, 1297598, 16277731.
19. Hess JR, Lindell AL, Stansbury LG, Dutton RP, Scalea TM. The prevalence of abnormal results of conventional coagulation tests on admission to a trauma center. Transfusion 2009, 49:34-39. 10.1111/j.1537-2995.2008.01944.x, 18954393.
20. Muggeo VMR. Estimating regression models with unknown break-points. Stat Med 2003, 22:3055-3071. 10.1002/sim.1545, 12973787.
21. Wood SN. Generalized Additive Models: An Introduction with R 2006, Boca Raton, FL: Chapman & Hall/CRC.
22. Akaike H. A new look at the statistical model identification. Automat Contr 1974, 19:716-723.
23. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, Stanworth S, Brohi K. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012, 10:1342-1351. 10.1111/j.1538-7836.2012.04752.x, 22519961.
24. Sørensen B, Larsen O, Rea C, Tang M, Foley J, Fenger-Eriksen C. Fibrinogen as a hemostatic agent. Semin Thromb Hemost 2012, 38:268-273.
25. Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009, 102:137-144.
26. Schultz DR, Arnold PI. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum 1990, 20:129-147. 10.1016/0049-0172(90)90055-K, 1705051.
27. Corrado E, Rizzo M, Coppola G, Fattouch K, Novo G, Marturana I, Ferrara F, Novo S. An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb 2010, 17:1-11. 10.5551/jat.2600, 20032572.
28. Champion HR, Copes WS, Sacco WJ, Lawnick MM, Bain LW, Gann DS, Gennarelli T, Mackenzie E, Schwaitzberg S. A new characterization of injury severity. J Trauma Injury Infect Crit Care 1990, 30:539-545. discussion 545-546.
29. MacLeod JBA, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma Injury Infect Crit Care 2003, 55:39-44.
30. Brown LM, Call MS, Margaret Knudson M, Cohen MJ. A normal platelet count may not be enough: the impact of admission platelet count on mortality and transfusion in severely injured trauma patients. J Trauma Injury Infect Crit Care 2011, 71:S337-S342.
31. Holcomb JB, Zarzabal LA, Michalek JE, Kozar RA, Spinella PC, Perkins JG, Matijevic N, Dong JF, Pati S, Wade CE. Increased platelet:RBC ratios are associated with improved survival after massive transfusion. J Trauma Injury Infect Crit Care 2011, 71:S318-S328.
32. Wohlauer MV, Moore EE, Thomas S, Sauaia A, Evans E, Harr J, Silliman CC, Ploplis V, Castellino FJ, Walsh M. Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma. ACS. J Am Coll Surg 2012, 214:739-746.
33. Martini WZ, Holcomb JB. Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg 2007, 246:831-835. 10.1097/SLA.0b013e3180cc2e94, 17968176.
34. Amin H, Mohsin S, Aslam M, Hussain S, Saeed T, Ullah MI, Sami W. Coagulation factors and antithrombin levels in young and elderly subjects in Pakistani population. Blood Coagul Fibrinolysis 2012, 23:745-750. 10.1097/MBC.0b013e328358e913, 23135380.
35. Husebye EE, Lyberg T, Opdahl H, Aspelin T, Støen R, Madsen JE, Røise O. Intramedullary nailing of femoral shaft fractures in polytraumatized patients. A longitudinal, prospective and observational study of the procedure-related impact on cardiopulmonary- and inflammatory responses. Scand J Trauma Resusc Emerg Med 2012, 20:2. 10.1186/1757-7241-20-2, 3285514, 22221511.
36. Dahl OE, Johnsen H, Kierulf P, Molnar I, Rø JS, Vinje A, Pape HC, Schmidt RE, Rice J, van Griensven M, das Gupta R, Krettek C, Tscherne H. Biochemical changes after trauma and skeletal surgery of the lower extremity: quantification of the operative burden. Crit Care Med 2000, 28:3441-3448. 10.1097/00003246-200010000-00012, 11057799.
37. Wozasek GE, Simon P, Redl H, Schlag G. Intramedullary pressure changes and fat intravasation during intramedullary nailing: an experimental study in sheep. J Trauma Injury Infect Crit Care 1994, 36:202-207.
38. Dahl OE, Johnsen H, Kierulf P, Molnar I, Rø JS, Vinje A, Mowinckel P. Intrapulmonary thrombin generation and its relation to monomethylmethacrylate plasma levels during hip arthroplasty. Acta Anaesthesiol Scand 1992, 36:331-335. 10.1111/j.1399-6576.1992.tb03477.x, 1595339.
39. Dahl OE, Pedersen T, Kierulf P, Westvik AB, Lund P, Arnesen H, Seljeflot I, Abdelnoor M, Lyberg T. Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res 1993, 70:451-458. 10.1016/0049-3848(93)90087-5, 8362370.
40. Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 1995, 6:743-746. 10.1097/00001721-199512000-00008, 8825225.